Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

about

HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.

P2860

Q47646979-908FF880-DDCB-40D2-90F0-3008095DD519 Q51365549-52389168-0B30-4E28-AE7B-F8BB9A233B1D

P2860

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

Item

http://www.wikidata.org/entity/Q36900055

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cryptococcal Antigenemia in Ni ...... tiretroviral Therapy Adherence

@en

type

Item

label

Cryptococcal Antigenemia in Ni ...... tiretroviral Therapy Adherence

@en

prefLabel

Cryptococcal Antigenemia in Ni ...... tiretroviral Therapy Adherence

@en

P1476

Cryptococcal Antigenemia in Ni ...... tiretroviral Therapy Adherence

@en

P2093

Alani S Akanmu

http://www.w3.org/2001/XMLSchema#string

Augustina O Nwosu

http://www.w3.org/2001/XMLSchema#string

Folasade T Ogunsola

http://www.w3.org/2001/XMLSchema#string

Malcolm D Richardson

http://www.w3.org/2001/XMLSchema#string

Rita O Oladele

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings

Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.

High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.

HIV infection: epidemiology, pathogenesis, treatment, and prevention.

Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria.

Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis.

P304

ofw055

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFW055

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David W. Denning

P577

2016-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27186581

http://www.w3.org/2001/XMLSchema#string

P921

Nigeria

P932

4866571

http://www.w3.org/2001/XMLSchema#string

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

about

P2860

P2860

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932